Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Cr2Te3 Thin Films for Integration in Magnetic Topological Insulator Heterostructures.

Burn DM, Duffy LB, Fujita R, Zhang SL, Figueroa AI, Herrero-Martin J, van der Laan G, Hesjedal T.

Sci Rep. 2019 Jul 25;9(1):10793. doi: 10.1038/s41598-019-47265-7.

2.

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline [Internet].

Waites KB, Bade DJ, Bébéar C, Brown SD, Davidson MK, Duffy LB, Kenny G, Matlow A, Shortridge D, Talkington D, Totten PA, Watts JL, Zheng X.

Wayne (PA): Clinical and Laboratory Standards Institute; 2011 Oct.

3.

The effect of substrate and surface plasmons on symmetry breaking at the substrate interface of the topological insulator Bi2Te3.

Wiesner M, Roberts RH, Lin JF, Akinwande D, Hesjedal T, Duffy LB, Wang S, Song Y, Jenczyk J, Jurga S, Mroz B.

Sci Rep. 2019 Apr 16;9(1):6147. doi: 10.1038/s41598-019-42598-9.

4.

Systematic Study of Ferromagnetism in CrxSb2-xTe3 Topological Insulator Thin Films using Electrical and Optical Techniques.

Singh A, Kamboj VS, Liu J, Llandro J, Duffy LB, Senanayak SP, Beere HE, Ionescu A, Ritchie DA, Hesjedal T, Barnes CHW.

Sci Rep. 2018 Nov 19;8(1):17024. doi: 10.1038/s41598-018-35118-8.

5.

Electronic Structure and Enhanced Charge-Density Wave Order of Monolayer VSe2.

Feng J, Biswas D, Rajan A, Watson MD, Mazzola F, Clark OJ, Underwood K, Marković I, McLaren M, Hunter A, Burn DM, Duffy LB, Barua S, Balakrishnan G, Bertran F, Le Fèvre P, Kim TK, van der Laan G, Hesjedal T, Wahl P, King PDC.

Nano Lett. 2018 Jul 11;18(7):4493-4499. doi: 10.1021/acs.nanolett.8b01649. Epub 2018 Jun 22.

PMID:
29912565
6.

Crossover from lattice to plasmonic polarons of a spin-polarised electron gas in ferromagnetic EuO.

Riley JM, Caruso F, Verdi C, Duffy LB, Watson MD, Bawden L, Volckaert K, van der Laan G, Hesjedal T, Hoesch M, Giustino F, King PDC.

Nat Commun. 2018 Jun 13;9(1):2305. doi: 10.1038/s41467-018-04749-w.

7.

In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Xiao L, Duffy LB.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01064-17. doi: 10.1128/AAC.01064-17. Print 2017 Oct.

8.

In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.

Waites KB, Crabb DM, Duffy LB, Jensen JS, Liu Y, Paukner S.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02008-16. doi: 10.1128/AAC.02008-16. Print 2017 Feb.

9.

In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Liu Y, Duffy LB.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7502-7504. Print 2016 Dec.

10.

In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Duffy LB, Huband MD.

Antimicrob Agents Chemother. 2015;59(6):3627-9. doi: 10.1128/AAC.04945-14. Epub 2015 Mar 30.

11.

Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.

Ratliff AE, Duffy LB, Waites KB.

J Clin Microbiol. 2014 Apr;52(4):1060-3. doi: 10.1128/JCM.02913-13. Epub 2014 Jan 15.

12.

Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.

Acosta EP, Grigsby PL, Larson KB, James AM, Long MC, Duffy LB, Waites KB, Novy MJ.

J Infect Dis. 2014 Mar;209(6):898-904. doi: 10.1093/infdis/jit578. Epub 2013 Oct 31.

13.

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.

Grigsby PL, Novy MJ, Sadowsky DW, Morgan TK, Long M, Acosta E, Duffy LB, Waites KB.

Am J Obstet Gynecol. 2012 Dec;207(6):475.e1-475.e14. doi: 10.1016/j.ajog.2012.10.871. Epub 2012 Oct 23.

14.

Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.

Waites KB, Duffy LB, Bébéar CM, Matlow A, Talkington DF, Kenny GE, Totten PA, Bade DJ, Zheng X, Davidson MK, Shortridge VD, Watts JL, Brown SD.

J Clin Microbiol. 2012 Nov;50(11):3542-7. doi: 10.1128/JCM.01439-12. Epub 2012 Aug 22.

15.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, Waites KB, Glass JI.

BMC Microbiol. 2012 May 30;12:88. doi: 10.1186/1471-2180-12-88.

16.

Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Waites KB.

Antimicrob Agents Chemother. 2012 May;56(5):2780-3. doi: 10.1128/AAC.06342-11. Epub 2012 Feb 27.

17.

Genotypic characterization of ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.

Xiao L, Crabb DM, Moser SA, Duffy LB, Glass JI, Paralanov V, Waites KB.

J Clin Microbiol. 2011 Sep;49(9):3325-8. doi: 10.1128/JCM.01235-11. Epub 2011 Jul 27.

18.

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB.

J Clin Microbiol. 2011 Aug;49(8):2818-26. doi: 10.1128/JCM.00637-11. Epub 2011 Jun 22.

19.

Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Hamilos DL, Waites KB.

Int J Antimicrob Agents. 2011 Apr;37(4):377-9. doi: 10.1016/j.ijantimicag.2010.12.012. Epub 2011 Feb 24.

PMID:
21353494
20.

Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.

Lai JF, Zindl CL, Duffy LB, Atkinson TP, Jung YW, van Rooijen N, Waites KB, Krause DC, Chaplin DD.

PLoS One. 2010 Dec 23;5(12):e14417. doi: 10.1371/journal.pone.0014417.

21.

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB.

J Clin Microbiol. 2010 Aug;48(8):2715-23. doi: 10.1128/JCM.01877-09. Epub 2010 Jun 16.

22.

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.

Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB.

Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.

PMID:
19633515
23.

Deficient immune response to Mycoplasma pneumoniae in childhood asthma.

Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):158-65. doi: 10.2500/aap.2009.30.3207.

PMID:
19463205
24.

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2009 May;53(5):2139-41. doi: 10.1128/AAC.00090-09. Epub 2009 Mar 2.

25.

Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2008 Oct;52(10):3776-8. doi: 10.1128/AAC.00849-08. Epub 2008 Jul 28.

26.
28.

Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresis.

Moser SA, Mayfield CA, Duffy LB, Waites KB.

J Microbiol Methods. 2006 Dec;67(3):606-10. Epub 2006 Jul 21.

PMID:
16859785
29.

A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.

Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP.

Microb Pathog. 2005 Oct;39(4):149-58.

PMID:
16169702
30.
31.

In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.

Hilliard NJ, Duffy LB, Crabb DM, Waites KB.

J Microbiol Methods. 2005 Feb;60(2):285-8.

PMID:
15590104
33.

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH Jr.

Pediatrics. 2004 Apr;113(4):701-7.

PMID:
15060215
35.

Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon.

Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH.

Pediatr Res. 2003 Dec;54(6):797-807. Epub 2003 Aug 20.

PMID:
12930907
36.

Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.

Duffy LB, Crabb DM, Bing X, Waites KB.

J Antimicrob Chemother. 2003 Sep;52(3):527-8. Epub 2003 Jul 29. No abstract available.

PMID:
12888583
37.

Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.

Waites KB, Crabb DM, Duffy LB.

Int J Antimicrob Agents. 2003 Jun;21(6):574-7.

PMID:
12791472
38.
39.

In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2003 Jan;47(1):39-42.

40.

Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

Hoek KL, Cassell GH, Duffy LB, Atkinson TP.

J Allergy Clin Immunol. 2002 Mar;109(3):470-6.

PMID:
11897994
41.

Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.

Lu GC, Schwebke JR, Duffy LB, Cassell GH, Hauth JC, Andrews WW, Goldenberg RL.

Am J Obstet Gynecol. 2001 Jul;185(1):163-5.

PMID:
11483922
42.

Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.

Duffy LB, Crabb D, Searcey K, Kempf MC.

J Antimicrob Chemother. 2000 Apr;45 Suppl 1:29-33.

PMID:
10824029
43.

Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in southern California.

Gray GC, Duffy LB, Paver RJ, Putnam SD, Reynolds RJ, Cassell GH.

Mil Med. 1997 Aug;162(8):524-6.

PMID:
9271902
44.

Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.

Waites KB, Crabb DM, Duffy LB, Cassell GH.

Diagn Microbiol Infect Dis. 1997 Apr;27(4):117-22.

PMID:
9154407
45.

Isolation of Ureaplasma urealyticum from low birth weight infants.

Waites KB, Cassell GH, Duffy LB, Searcey KB.

J Pediatr. 1995 Mar;126(3):502; author reply 503-4. No abstract available.

PMID:
7869217
46.

Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.

Waites KB, Sims PJ, Crouse DT, Geerts MH, Shoup RE, Hamrick WB, Duffy LB, Cassell GH.

Pediatr Infect Dis J. 1994 Apr;13(4):287-93.

PMID:
8036045
47.

Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus.

Clough W, Cassell GH, Duffy LB, Rinaldi RZ, Bluestone R, Morgan MA, Meyer RD.

Clin Infect Dis. 1992 Sep;15(3):402-7.

PMID:
1520784
48.

Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline.

Blanchard A, Crabb DM, Dybvig K, Duffy LB, Cassell GH.

FEMS Microbiol Lett. 1992 Aug 15;74(2-3):277-81.

PMID:
1526460
49.

Mycoplasmal infections of cerebrospinal fluid in children undergoing neurosurgery for hydrocephalus.

Waites KB, Duffy LB, Baldus K, Aronin PA, Cassell GH.

Pediatr Infect Dis J. 1991 Dec;10(12):952-3. No abstract available.

PMID:
1766714
50.

In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Waites KB, Duffy LB, Schmid T, Crabb D, Pate MS, Cassell GH.

Antimicrob Agents Chemother. 1991 Jun;35(6):1181-5.

Supplemental Content

Loading ...
Support Center